Comparison of topical tranexamic versus nasal tampon in epistaxis

Not Applicable

Recruiting

• Conditions: Epistaxis.; Epistaxis; R04.0

• Registration Number: IRCT20160130026253N3
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 162

Inclusion Criteria

patients with unilateral idiopathic anterior epistaxis

Exclusion Criteria

Posterior epistaxis
A history of bleeding disorders such as thrombocytopenia, hemophilia and platelet disorders
Seizure
Arterial or intravenous thrombosis
Use of anticoagulants, platelets and aspirin

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Stop the bleeding. Timepoint: Every 5 minutes. Method of measurement: stopwatch.;Rate of rebleeding. Timepoint: During the first 24 hours as well as the first week after intervention. Method of measurement: stopwatch.